Brief: Guard Therapeutics To Get About SEK 7.2 Mln Through Rights Issue
Sept 25 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* SAID ON TUESDAY ABOUT 8.9% OF RIGHTS ISSUE WAS SUBSCRIBED
* WILL GET ABOUT SEK 7.2 MLN THROUGH RIGHTS ISSUE
Source text for Workspace: urn:newsml:reuters.com:*:nMFN964cpG
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover